Overview

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Fluticasone
Olopatadine Hydrochloride
Xhance